PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
p115 RhoGEF (D25D2) Rabbit Monoclonal Antibody
#3669 · $175
100
Citing papers
10.8k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Acute Myeloid Leukemia Research
10
Chronic Myeloid Leukemia Treatments
10
Ubiquitin and proteasome pathways
7
Adipose Tissue and Metabolism
5
Cancer-related molecular mechanisms research
5
Fatty Acid Research and Health
5
Autophagy in Disease and Therapy
5
Cancer Cells and Metastasis
4
Papers citing this product
1
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Blood
·
2009
·
641 cit.
·
DOI
2
B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity
Nature
·
2021
·
428 cit.
·
DOI
3
Mutant FLT3: A Direct Target of Sorafenib in Acute Myelogenous Leukemia
JNCI Journal of the National Cancer Institute
·
2008
·
338 cit.
·
DOI
4
Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α
Blood
·
2005
·
300 cit.
·
DOI
5
TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT
Scientific Reports
·
2015
·
251 cit.
·
DOI
6
Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis
Journal of Clinical Investigation
·
2016
·
241 cit.
·
DOI
7
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model
Human Molecular Genetics
·
2011
·
223 cit.
·
DOI
8
Lnc-mg is a long non-coding RNA that promotes myogenesis
Nature Communications
·
2017
·
212 cit.
·
DOI
9
mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning
Neuropsychopharmacology
·
2009
·
208 cit.
·
DOI
10
Endothelial β <sub>3</sub> -Adrenoreceptors Mediate Nitric Oxide–Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation β-Blocker Nebivolol
Circulation
·
2005
·
205 cit.
·
DOI
Show 90 more papers
Feedback